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Abstract
Purpose: Tumor orthopedic surgery has higher incidences of Surgical Site Infections (SSI) than 
non-oncologic surgery. However, their epidemiologic microbiology is rarely published.
Methods: In our large tertiary composite database of orthopedic infections, we compare SSIs in 
adult oncologic patients to adult non-oncologic patients.
Results: Among 2752 different first episodes of orthopedic infections in adults, only 14 (0.5%) 
concerned SSI at the site of prior oncologic surgery. Oncologic patients had no more prior antibiotic 
therapy (before intraoperative samplings) than non-oncologic patients, but they witnessed 
significantly more SSIs due to enterococci, Gram-negative pathogens, or infections due to multi-
resistant skin commensals. In contrast, the proportion of classic orthopedic pathogens such as 
Staphylococcus aureus or streptococci was not different from the control group. We couldn’t link the 
germs to prior oncologic treatment, nor to the length of perioperative surgical antibiotic prophylaxis.
Conclusion: The microbiology of orthopedic SSI in adult oncologic patients is significantly different 
than in non-oncologic patients. Retrospectively, the standard antibiotic prophylaxis is inadequate 
for the involved pathogens. More studies are needed to tailor a specific perioperative prophylaxis in 
terms of choice of the agents, rather than of duration of the standard prophylaxis.
Type of study/Level of evidence: III, Retrospective study.
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Introduction
In adult orthopedic oncology, Surgical Site Infections (SSI) occurs much more frequently after 
interventions for Soft-Tissue (STS) or Bone Sarcoma (BS) than after non-oncologic orthopedic 
interventions. Their incidence might be as much as 30% [1]. Despite an emerging field of research, 
publications regarding their microbiology are surprisingly scant. In this study, we compared SSI 
in adult oncologic patients to adult non-oncologic patients and perform a literature review, which 
might have practical consequences in daily clinical life and future research.
Methods
Our Orthopedic Service has several databases regarding infections among adult patients [2]. 
Both authors retrospectively compared the epidemiology of oncologic SSI and non-oncologic SSI 
(first episodes) by the Pearson-χ2, Fisher-exact or the Wilcoxon-ranksum-tests. We defined infection 
as pus, same positive results in several intraoperative microbiological samples, and as a clinically 
new local inflammation responding to systemic antibiotic therapy. We excluded colonizations and 
subsequent episodes of infections. For the literature search (English and French), we used the MeSH 
terms “sarcoma”, and “postoperative complication”, and “infection”, with exclusion of “Kaposi”, in 
PubMed and Google Scholar.
Results
Among 2752 different first episodes of various orthopedic infections, only 14 (0.5%) concerned 
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SSI at the site of prior oncologic surgery. Oncologic patients had 
no more prior antibiotic therapy (before intraoperative samplings) 
than non-oncologic patients, but witnessed a particular pattern of 
microorganisms, which were characterized by more enterococci, 
Gram-negative pathogens, or infections due to multi-resistant 
skin commensals. In contrast, the proportion of classic orthopedic 
pathogens such as Staphylococcus aureus or streptococci was not 
different from the control group (Table 1). Of note, we couldn’t 
link the type of germs to prior preoperative chemotherapy or 
radiotherapy, nor with the length of prophylactic or prior therapeutic 
antibiotic therapy.
Literature Review
Of the 484 articles sorted according to our search criteria, 
only eight included useful microbiological data about SSI in adult 
orthopedic sarcomas [1,3-9]. We couldn’t find a single publication 
specifically about the epidemiology of the pathogens in orthopedic 
oncology SSI. Our findings partly correspond to the literature (Table 
2), however with more polymicrobial infections, Gram-negative 
pathogens and enterococci.
Discussion
In our adult oncologic orthopedic population, we found 
substantially more enterococci, Gram-negative pathogens (including 
Pseudomonas aeruginosa) and anaerobes, or infections due to multi-
resistant skin commensals (except for cutibacteria) compared to 
non-oncologic infections [10-15]. These were mostly pathogens not 
covered by standard antibiotic prophylaxis. Hence, they might be 
n=2752 (Prior) cancer n=14 p value* No prior cancer n=2738
Female sex 6 (43%) 0.375 870 (32%)
Median age 49 years 0.647 57 years
Prior antibiotics before sampling 3 (21%) 0.109 1168 (43%)
Median duration of prior antibiotics 1 day 0.183 4 days
Type of infection
Osteoarticular infections 5 (36%) 0.538 1202 (44%)
Implant-related infections 2 (14%) 0.384 665 (24%)
Prosthetic joint infection 1 (7%) 0.595 321 (12%)
Bacteraemia 0 (0%) 0.174 319 (12%)
Fasciitis 0 (0%) 0.748 20 (1%)
Presence of abscesses 10 (71%) 0.013 1069 (39%)
Causative pathogen(s)
Staphylococcus aureus 3 (21%) 0.098 1051 (43%)
Streptococci 2 (14%) 0.902 358 (13%)
Skin commensals 7 (50%) 0.001 292 (12%)
Propionibacterium acnes 0 (0%) 0.661 37 (1%)
Enterococci 6 (43%) 0.001 101 (4%)
Gram-negative pathogens 10 (71%) 0.001 567 (21%)
Anaerobes 3 (21%) 0.001 65 (2%)
Non-fermenting rods 9 (64%) 0.001 257 (11%)
Pseudomonas aeruginosa 6 (43%) 0.001 177 (6%)
Polymicrobial 10 (71%) 0.001 573 (24%)
Table 1: Comparisons of microbiology of orthopaedic infections stratified upon patients with and without (prior) orthopaedic cancer at the site of infection.
*Significant p values ≤ 0.05 (two-tailed) are displayed in bold and italic.
Author, year Journal No. patients
Main microbiological findings
Polymicrobials Skin commensals Gram-neg Enterococci S aureus
Mavrogenis, 2015 Surgical infections 100 8% 47% na na 19%
Peel, 2014 EJSO 17 18% 35% na na 29%
Angelini, 2014 CORR 55 38% na 37% na na
Hardes, 2010 J Surg Oncol 16 25% 25% na 19% 6%
Lee, 2009 Ann Surg Oncol 31 na 16% 6% 3% 23%
Jeys, 2007 Ann Surg Oncol 41 na 52% na na 29%
Hardes, 2006 Arch Orthop Trauma Surg 29 21% 60% 14% 13% 20%
Lee, 2002 SICOT 18 0 44% 0 na 28%
Present study  14 71% 50% 71% 43% 21%
Table 2: Microbiology of infections in orthopaedic tumor surgery (selected literature).
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selections, in as much as the standard cephalosporin prophylaxis 
covers the susceptible (Gram-positive) pathogens and leaving 
behind these “resistant” pathogens which are typically encountered 
in macerations and ischemic areas. We question thus the utility 
of standard antibiotic prophylaxis, which might not be enough. 
Studies concerning the microorganisms of oncologic SSI are rare. 
Possible reasons might include difficulties to gather enough cases or 
the lack of interest for such a specific subject. We found only one 
currently ongoing prospective study on the subject, the PARITY 
trial (ClinicalTrials.gov NCT01479283), comparing two prophylactic 
cefazolin durations (1 vs. 5 days) but without microbiological analysis 
of the causative agents. According to our retrospective assessment, 
cefazolin or cefuroxime would fail to cover the majority of the 
infecting pathogens we have noted.
Conclusion
The microbiology of orthopedic SSI in adult oncologic patients is 
significantly different than in non-oncologic patients. The standard 
antibiotic prophylaxis is inadequate for the involved pathogens 
and the literature on this subject is lacking. Clearly, more studies 
are needed in order to tailor a specific perioperative prophylaxis in 
terms of choice of the agents, rather than of duration of the standard 
perioperative prophylaxis.
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